Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Vaxess Technologies, Inc.
*MAILING ADDRESS
790 Memorial Drive, Suite 200
*CITY
Cambridge
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02139
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceuticals, namely, pain relief medication and hormones for medical purposes; vaccines; immunotherapies for the treatment of cancer,
autoimmune diseases or disorders, and allergies; drug delivery agents in the form of patches that provide transdermal delivery of the active ingredient for a wide range of pharmaceuticals; drug
delivery agents in the form of polymers that facilitate the sustained release of a wide range of pharmaceuticals; drug delivery agents in the form of resorbable microneedles that facilitate the
transdermal delivery of pharmaceuticals, pre-filled with vaccines; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled
with immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery
of pharmaceuticals, pre-filled with pain relief medication; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with
hormones for medical purposes.
FILING BASIS
SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT
Applicant is the owner of Application Serial No. 87181775 for MIMIX.
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:90182815
Filing Date:09/15/2020
To the Commissioner for Trademarks:
MARK: MIMIX (Standard Characters, see mark)
The literal element of the mark consists of MIMIX. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Vaxess Technologies, Inc., a corporation of Delaware, having an address of
790 Memorial Drive, Suite 200
Cambridge, Massachusetts 02139
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceuticals, namely, pain relief medication and hormones for medical purposes; vaccines; immunotherapies for the treatment of cancer, autoimmune diseases or
disorders, and allergies; drug delivery agents in the form of patches that provide transdermal delivery of the active ingredient for a wide range of pharmaceuticals; drug delivery agents in the form
of polymers that facilitate the sustained release of a wide range of pharmaceuticals; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of
pharmaceuticals, pre-filled with vaccines; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with immunotherapies for
the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals,
pre-filled with pain relief medication; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with hormones for medical
purposes.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Miscellaneous Statement
Applicant is the owner of Application Serial No. 87181775 for MIMIX.
The owner's/holder's proposed attorney information: Nicole Kinsley, Esq.. Other appointed attorneys are Joshua Jarvis, Esq., Natasha Reed, Esq., Jenevieve Maerker, Esq., Jennifer Yoo,
Esq.. Nicole Kinsley, Esq. of Foley Hoag LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
155 Seaport Boulevard
Boston, Massachusetts 02210
United States
617-832-1000(phone)
617-832-7000(fax)
ustrademark@foleyhoag.com
The docket/reference number is 31110.00014.
Nicole Kinsley, Esq. submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).